Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study.

Arthritis care & research

Volumn 62, Issue 12, 2010, Pages 1772-1778

  Au, Karen ^a   Mayes, Maureen D ^b   Maranian, Paul ^b   Clements, Philip J ^b   Khanna, Dinesh ^b   Steen, Virginia D ^b   Tashkin, Donald ^b   Roth, Michael D ^b   Elashoff, Robert ^b   Furst, Daniel E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; LOCALIZED SCLERODERMA; MALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SKIN ULCER; SYSTEMIC SCLEROSIS;

ADMINISTRATION, ORAL; CYCLOPHOSPHAMIDE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROGNOSIS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SKIN ULCER;

MLCS; MLOWN;

EID: 79952117169     PISSN: None     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.20320     Document Type: Article

References (0)